These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24231915)

  • 41. [Graves' orbitopathy].
    Balázs C
    Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management plan and delivery of care in Graves' ophthalmopathy patients.
    Yang M; Perros P
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):303-11. PubMed ID: 22632367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Effect of Systemic Steroids and Orbital Radiation for Active Graves Orbitopathy on Postdecompression Extraocular Muscle Volume.
    Kim JW; Lee KH; Woo YJ; Kim J; Keum KC; Yoon JS
    Am J Ophthalmol; 2016 Nov; 171():11-17. PubMed ID: 27542927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Orbital wall decompression in the management of Graves' orbitopathy: a systematic review with meta-analysis.
    Gioacchini FM; Kaleci S; Cassandro E; Scarpa A; Tulli M; Cassandro C; Ralli M; Re M
    Eur Arch Otorhinolaryngol; 2021 Nov; 278(11):4135-4145. PubMed ID: 33599843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Thyroid associated orbitopathy: from diagnosis to treatment].
    Hamédani M; Obéric A
    Rev Med Suisse; 2013 Jan; 9(368):66-71. PubMed ID: 23367708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-Dose Rituximab for Active Moderate to Severe Graves' Orbitopathy Resistant to Conventional Treatment.
    Du Pasquier-Fediaevsky L; Andrei S; Berche M; Leenhardt L; Héron E; Rivière S
    Ocul Immunol Inflamm; 2019; 27(5):844-850. PubMed ID: 29652204
    [No Abstract]   [Full Text] [Related]  

  • 47. Impact of the ethmoid volume on endoscopic medial wall decompression outcomes in Graves' orbitopathy.
    Clarós P; Waląg A; López-Fortuny M; Clarós A
    Acta Otolaryngol; 2020 Nov; 140(11):948-953. PubMed ID: 32957802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Graves' disease and exophthalmos - a mask for meningioma.
    Mitka K; Sokołowski G; Pach D; Hubalewska-Dydejczyk A
    Endokrynol Pol; 2021; 72(2):179-180. PubMed ID: 33619715
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endocrine orbitopathy: 11 years retrospective study and review of 102 patients & 196 orbits.
    Clauser LC; Galiè M; Tieghi R; Carinci F
    J Craniomaxillofac Surg; 2012 Feb; 40(2):134-41. PubMed ID: 22041435
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Malignant exophtalmos in hyperthyroidism with a hypothyroid crisis].
    Campos-Pavón J; Mencía-Gutiérrez E; Gutiérrez-Díaz E
    Arch Soc Esp Oftalmol; 2006 Dec; 81(12):721-4. PubMed ID: 17199168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endoscopic orbital decompression for Graves' ophthalmopathy.
    Tang IP; Prepageran N; Shashinder S
    Med J Malaysia; 2008 Mar; 63(1):67-8. PubMed ID: 18935740
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surgical decompression in endocrine orbitopathy. Visual evoked potential evaluation and effect on the optic nerve.
    Clauser LC; Tieghi R; Galie' M; Franco F; Carinci F
    J Craniomaxillofac Surg; 2012 Oct; 40(7):621-5. PubMed ID: 22424910
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Management of Graves' orbitopathy: evidence-based recommendations].
    Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
    Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Orbital decompression for thyroid orbitopathy].
    Babiński D; Skorek A; Nałęcz A; Stankiewicz C
    Otolaryngol Pol; 2011; 65(4):262-5. PubMed ID: 22000142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sight-threatening Graves' orbitopathy: Twenty years' experience of a multidisciplinary thyroid-eye outpatient clinic.
    Tramunt B; Imbert P; Grunenwald S; Boutault F; Caron P
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):208-213. PubMed ID: 30339291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postoperative Changes in Strabismus, Ductions, Exophthalmometry, and Eyelid Retraction After Orbital Decompression for Thyroid Orbitopathy.
    Rootman DB; Golan S; Pavlovich P; Rootman J
    Ophthalmic Plast Reconstr Surg; 2017; 33(4):289-293. PubMed ID: 27487726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The influence of previous orbital irradiation on the outcome of rehabilitative decompression surgery in graves orbitopathy.
    Baldeschi L; MacAndie K; Koetsier E; Blank LE; Wiersinga WM
    Am J Ophthalmol; 2008 Mar; 145(3):534-540. PubMed ID: 18191092
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Graves' orbitopathy: Diagnosis and treatment.
    Drui D; Du Pasquier Fediaevski L; Vignal Clermont C; Daumerie C
    Ann Endocrinol (Paris); 2018 Dec; 79(6):656-664. PubMed ID: 30177259
    [No Abstract]   [Full Text] [Related]  

  • 59. Transpalpebral decompression of endocrine ophthalmopathy by intraorbital fat removal (Olivari technique): experience and progression after more than 3000 operations over 20 years.
    Richter DF; Stoff A; Olivari N
    Plast Reconstr Surg; 2007 Jul; 120(1):109-123. PubMed ID: 17572552
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Orbital Expansion in Cranial Vault After Minimally Invasive Extradural Transorbital Decompression for Thyroid Orbitopathy.
    Ramesh S; Nobori A; Wang Y; Rootman D; Goldberg RA
    Ophthalmic Plast Reconstr Surg; 2019; 35(1):17-21. PubMed ID: 29879083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.